Search Results - "Tribble, James R."

Refine Results
  1. 1
  2. 2

    Sholl analysis: A quantitative comparison of semi-automated methods by Binley, Kate E., Ng, Wai S., Tribble, James R., Song, Bing, Morgan, James E.

    Published in Journal of neuroscience methods (30-03-2014)
    “…•We compare four Sholl analysis methods to the manual method.•We validate two Sholl analysis methods.•We highlight two errors in two Sholl analysis methods…”
    Get full text
    Journal Article
  3. 3

    Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma by Williams, Pete A, Tribble, James R, Pepper, Keating W, Cross, Stephen D, Morgan, B Paul, Morgan, James E, John, Simon W M, Howell, Gareth R

    Published in Molecular neurodegeneration (06-04-2016)
    “…Glaucoma is a complex, multifactorial disease characterised by the loss of retinal ganglion cells and their axons leading to a decrease in visual function. The…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J mice by Tribble, James R, Harder, Jeffrey M, Williams, Pete A, John, Simon W M

    Published in Molecular brain (25-05-2020)
    “…Glaucoma is the leading cause of irreversible vision loss. Ocular hypertension is a major risk factor for glaucoma and recent work has demonstrated critical…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients by Rutigliani, Carola, Tribble, James R, Hagström, Anna, Lardner, Emma, Jóhannesson, Gauti, Stålhammar, Gustav, Williams, Pete A

    Published in Acta neuropathologica communications (19-08-2022)
    “…Neuroinflammation is recognized as a key component of neurodegenerative disease. In glaucoma, a common neurodegenerative disease and the leading cause of…”
    Get full text
    Journal Article
  9. 9

    NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve by Tribble, James R, Hagström, Anna, Jusseaume, Kenza, Lardner, Emma, Wong, Raymond Ching-Bong, Stålhammar, Gustav, Williams, Pete A

    Published in Acta neuropathologica communications (22-01-2023)
    “…Glaucoma is the leading cause of irreversible blindness and is a major health and economic burden. Current treatments do not address the neurodegenerative…”
    Get full text
    Journal Article
  10. 10

    Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma by Cimaglia, Gloria, Tribble, James R, Votruba, Marcela, Williams, Pete A, Morgan, James E

    Published in Acta neuropathologica communications (23-08-2024)
    “…A compromised capacity to maintain NAD pools is recognized as a key underlying pathophysiological feature of neurodegenerative diseases. NAD acts as a…”
    Get full text
    Journal Article
  11. 11

    Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume by Otmani, Amin, Jóhannesson, Gauti, Brautaset, Rune, Tribble, James R, Williams, Pete A

    Published in Acta neuropathologica communications (01-03-2024)
    “…Leber's hereditary optic neuropathy (LHON) is driven by mtDNA mutations affecting Complex I presenting as progressive retinal ganglion cell dysfunction usually…”
    Get full text
    Journal Article
  12. 12

    Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma by Tribble, James R, Hui, Flora, Jöe, Melissa, Bell, Katharina, Chrysostomou, Vicki, Crowston, Jonathan G, Williams, Pete A

    Published in Cells (Basel, Switzerland) (01-02-2021)
    “…Glaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive dysfunction and death of retinal ganglion cells occurs, eliminating transfer of…”
    Get full text
    Journal Article
  13. 13

    Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection by Rombaut, Anne, Jovancevic, Danica, Wong, Raymond Ching-Bong, Nicol, Alan, Brautaset, Rune, Finkelstein, David I, Nguyen, Christine T O, Tribble, James R, Williams, Pete A

    Published in Acta neuropathologica communications (21-05-2024)
    “…Neurodegenerative diseases have common underlying pathological mechanisms including progressive neuronal dysfunction, axonal and dendritic retraction, and…”
    Get full text
    Journal Article
  14. 14

    Glial metabolic alterations during glaucoma pathogenesis by Rombaut, Anne, Brautaset, Rune, Williams, Pete A, Tribble, James R

    Published in Frontiers in ophthalmology (2023)
    “…Glaucoma is the leading cause of irreversible blindness. Current treatment options are limited and often only slow disease progression. Metabolic dysfunction…”
    Get full text
    Journal Article
  15. 15

    Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection by Canovai, Alessio, Tribble, James R, Jöe, Melissa, Westerlund, Daniela Y, Amato, Rosario, Trounce, Ian A, Dal Monte, Massimo, Williams, Pete A

    Published in Acta neuropathologica communications (08-09-2023)
    “…Abstract Retinal ganglion cells are highly metabolically active requiring strictly regulated metabolism and functional mitochondria to keep ATP levels in…”
    Get full text
    Journal Article
  16. 16

    Valproic Acid Reduces Neuroinflammation to Provide Retinal Ganglion Cell Neuroprotection in the Retina Axotomy Model by Tribble, James R, Kastanaki, Elizabeth, Uslular, A Berşan, Rutigliani, Carola, Enz, Tim J, Williams, Pete A

    “…Neuroinflammation is a critical and targetable pathogenic component of neurodegenerative diseases, including glaucoma, the leading cause of irreversible…”
    Get full text
    Journal Article
  17. 17

    Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma by Tribble, James R, Vasalauskaite, Asta, Redmond, Tony, Young, Robert D, Hassan, Shoaib, Fautsch, Michael P, Sengpiel, Frank, Williams, Pete A, Morgan, James E

    Published in Brain communications (01-01-2019)
    “…Glaucoma is characterized by the progressive dysfunction and loss of retinal ganglion cells. However, the earliest degenerative events that occur in human…”
    Get full text
    Journal Article
  18. 18

    Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma by Tribble, James R, Williams, Pete A, Caterson, Bruce, Sengpiel, Frank, Morgan, James E

    Published in Molecular brain (21-11-2018)
    “…Retinal ganglion cell dendritic atrophy is an early feature of glaucoma, and the recovery of retinal ganglion cell dendrites is a viable option for vision…”
    Get full text
    Journal Article
  19. 19

    Microbead models in glaucoma by Morgan, James E., Tribble, James R.

    Published in Experimental eye research (01-12-2015)
    “…The sustained and moderate elevation of intraocular pressure, which can be initiated at precise time points, remains the cornerstone of research into the…”
    Get full text
    Journal Article
  20. 20

    Preventing retinal homocysteine dysregulation protects against retinal ganglion cell death by Tribble, James R., Rutigliani, Carola, Canovai, Alessio, Williams, Pete A.

    Published in Acta ophthalmologica (Oxford, England) (01-01-2024)
    “…Glaucoma, the most common cause of irreversible blindness, is characterized by progressive dysfunction and loss of retinal ganglion cells. There are no…”
    Get full text
    Journal Article